Mitochondrial Disruption by Amyloid Beta 42 Identified by Proteomics and Pathway Mapping.
Alzheimer Disease
/ genetics
Amyloid beta-Peptides
/ toxicity
Animals
Chromatography, Liquid
Energy Metabolism
/ drug effects
Mitochondria
/ drug effects
Nerve Degeneration
Neurons
/ drug effects
PC12 Cells
Peptide Fragments
/ toxicity
Peptide Mapping
Protein Interaction Maps
Proteome
Proteomics
Rats
Spectrometry, Mass, Electrospray Ionization
Tandem Mass Spectrometry
Alzheimer’s
amyloid
bioenergetics
mitochondria
prohibitin
proteomics
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
10 09 2021
10 09 2021
Historique:
received:
23
07
2021
revised:
23
08
2021
accepted:
31
08
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
17
11
2021
Statut:
epublish
Résumé
Alzheimer's disease (AD) is marked by chronic neurodegeneration associated with the occurrence of plaques containing amyloid β (Aβ) proteins in various parts of the human brain. An increase in several Aβ fragments is well documented in patients with AD and anti-amyloid targeting is an emerging area of therapy. Soluble Aβ can bind to various cell surface and intracellular molecules with the pathogenic Aβ
Identifiants
pubmed: 34572029
pii: cells10092380
doi: 10.3390/cells10092380
pmc: PMC8468661
pii:
doi:
Substances chimiques
Amyloid beta-Peptides
0
Peptide Fragments
0
Proteome
0
amyloid beta-protein (1-42)
0
Banques de données
figshare
['10.6084/m9.figshare.15157257']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
FEBS Lett. 2001 Apr 20;495(1-2):1-6
pubmed: 11322937
Front Neurosci. 2021 Apr 20;15:648410
pubmed: 33958984
Biophys Rev. 2017 Aug;9(4):405-419
pubmed: 28631243
J Neurochem. 2008 Aug;106(3):1371-7
pubmed: 18485099
J Cell Biol. 2013 Apr 1;201(1):97-111
pubmed: 23547030
Sci Rep. 2020 Mar 30;10(1):5696
pubmed: 32231242
Exp Brain Res. 2017 Mar;235(3):731-742
pubmed: 27866262
Am J Hum Genet. 1994 Mar;54(3):516-25
pubmed: 8116621
Biomolecules. 2020 Apr 23;10(4):
pubmed: 32340404
Nat Rev Mol Cell Biol. 2018 Nov;19(11):679-696
pubmed: 30194414
J Neurosci. 2009 Jul 15;29(28):9078-89
pubmed: 19605645
PLoS One. 2013 Nov 28;8(11):e81828
pubmed: 24312364
J Neurosci. 2006 Oct 11;26(41):10480-7
pubmed: 17035532
J Neuropathol Exp Neurol. 2005 Feb;64(2):113-22
pubmed: 15751225
Neuromolecular Med. 2010 Mar;12(1):1-12
pubmed: 20232515
Sci Rep. 2020 Nov 9;10(1):19340
pubmed: 33168903
J Neurosci. 2004 Jan 14;24(2):565-75
pubmed: 14724257
Front Neurosci. 2019 Jun 21;13:659
pubmed: 31293377
Mol Cell. 2010 Aug 27;39(4):632-40
pubmed: 20797633
Mt Sinai J Med. 2010 Jan-Feb;77(1):32-42
pubmed: 20101720
J Biol Chem. 2006 Nov 24;281(47):36401-10
pubmed: 17008324
J Alzheimers Dis. 2020;78(4):1345-1361
pubmed: 33325389
Mol Neurobiol. 2016 Jan;53(1):455-471
pubmed: 25465238
Biochim Biophys Acta. 2013 May;1827(5):598-611
pubmed: 23291191
Eur J Neurosci. 2010 Mar;31(5):788-96
pubmed: 20374280
Acta Pharmacol Sin. 2017 Sep;38(9):1205-1235
pubmed: 28713158
J Cell Sci. 2012 Nov 15;125(Pt 22):5502-13
pubmed: 22956546
J Neurochem. 2018 Jan;144(2):201-217
pubmed: 29164616
Front Neurosci. 2018 Jul 13;12:470
pubmed: 30057523
Anal Biochem. 2018 Jul 1;552:50-59
pubmed: 28711444
J Proteome Res. 2017 Apr 7;16(4):1410-1424
pubmed: 28217993
J Neurochem. 2012 Feb;120(3):440-52
pubmed: 22060133
Appl Clin Genet. 2015 Aug 27;8:189-200
pubmed: 26345236
J Neurochem. 2020 Nov;155(4):348-369
pubmed: 32320074
Biochem J. 2015 Mar 15;466(3):443-54
pubmed: 25748677
Alzheimers Res Ther. 2020 Aug 12;12(1):95
pubmed: 32787971
J Biol Chem. 1998 Dec 25;273(52):34813-9
pubmed: 9857007
Nat Commun. 2019 Aug 29;10(1):3885
pubmed: 31467276
Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14675-80
pubmed: 11724968
Cell Mol Life Sci. 2018 Jul;75(14):2577-2589
pubmed: 29704008
Oncogene. 2006 Sep 25;25(43):5854-63
pubmed: 16998500
Mol Neurodegener. 2019 Aug 2;14(1):32
pubmed: 31375134
Biochim Biophys Acta. 2011 Jun;1807(6):562-7
pubmed: 20950584